Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Organisation › Details

Libra Therapeutics Inc.

Libra Therapeutics is a biotechnology company focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases. The company is advancing three distinct and novel preclinical small molecule programs designed to increase autophagy and decrease production of neurotoxic protein aggregates. Libra Therapeutics was founded to capitalize on proprietary technologies and therapeutic assets from Axxam, a leading discovery research company. The company is based in San Diego. *


Period Start 2019-01-01 established (s-off
  Predecessor Axxam S.p.A.
Products Industry CNS drug
  Industry 2 drug development
Person Person Veinbergs, Isaac (Libra Therapeutics 202009– CEO)
Region Region San Diego, CA
  Country United States (USA)
  City n. a. San Diego, CA
    Address record changed: 2020-10-24
Basic data Employees n. a.
Record changed: 2020-09-24


Picture [iito] Plain Stupid Simple 650x80px

More documents for Libra Therapeutics Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top